Literature DB >> 1582890

Experimental metastasis of oncogene-transformed NIH 3T3 cells in chick embryo.

Y Endo1, M Seiki, H Uchida, M Noguchi, Y Kida, H Sato, M Mai, T Sasaki.   

Abstract

By means of a highly sensitive and quantitative assay for specific detection of metastasized tumor cells in chick embryonic organs using the polymerase chain reaction (PCR), we have examined the experimental metastatic ability of individual clones of NIH 3T3 cells, transformed with oncogenes: v-Ki-ras, v-Ha-ras, v-src, v-fos, and v-abl. Such a transformed clone had different metastatic abilities in different embryonic organs. Among them, two clones of NIH 3T3 cells transformed with ras-oncogenes (v-Ki-ras or v-Ha-ras) metastasized to liver and lungs of chick embryo, and grew there more rapidly than the other clones. The parental NIH 3T3 cells were detected as slight bands of PCR products after iv injection, indicating some cells were trapped in chick embryonic organs, but did not grow. These findings indicate that the transformed cells are able to invade the organ tissues and grow in embryonic chick organs, but non-metastatic cells such as the untransformed-NIH 3T3 cells are not able to grow in the secondary sites. These experiments clearly demonstrate the usefulness of this assay system to study genes involved in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582890      PMCID: PMC5918805          DOI: 10.1111/j.1349-7006.1992.tb00100.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

2.  A possibility of predicting metastatic ability of tumours by implantation into chick embryos. Epigenetic grading of metastasizing and non-metastasizing forms of a hamster lymphosarcoma.

Authors:  G V Sherbet; M S Lakshmi; D Guy
Journal:  Eur J Cancer       Date:  1980-04       Impact factor: 9.162

3.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

4.  Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.

Authors:  R J Muschel; J E Williams; D R Lowy; L A Liotta
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

Review 5.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

6.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Cells transformed with a ts viral src mutant are temperature sensitive for in vivo growth.

Authors:  A F Chambers; S Wilson
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

8.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

Review 9.  Oncogenes and metastatic progression.

Authors:  A H Greenberg; S E Egan; J A Wright
Journal:  Invasion Metastasis       Date:  1989

10.  Construction and isolation of a transforming murine retrovirus containing the src gene of Rous sarcoma virus.

Authors:  S M Anderson; E M Scolnick
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

View more
  1 in total

1.  Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endo; Kayoko Tabata; Taiichi Kawamura; Hyo-Yung Yun; Etsurou Bandou; Takuma Sasaki; Masahiro Miura
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.